Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you, mig
Who needs to contemplate a buyout when the company is close to being GIVEN AWAY?
He means call the NAMED PHYSICIANS who have been identified as performing CaverStem (as I suspect you knew).
I misunderstood your meaning—I thought you meant we drive them into silence by driving the PPS up and then raising our expectations with that. In the end, we may be saying similar things.
Do you think it’s OK for them to have completed only around 50 procedures in the last quarter (based on revs vs. COGS)—essentially one year into commercialization?
How about the fact that we have heard NOTHING about the following in so long that I can’t even remember the names (and not because I haven’t been engaged)?:
1. Gary Melz (I think that was his name)
2. Some woman that was allegedly a social media guru who worked for Dr. Gershman, but was supposedly coming onboard with CELZ
3. CaverStem INTERNATIONAL
4. Dr. Pushkar and Russia
5. Dr. Gershman
6. Dr. Ichim
And that’s just off the top of my head...
One correction, monte: “WE” alone didn’t chase them to the quiet side—many associated with CELZ were posting on social media 1.5-2 years ago about the evident efficacy of CaverStem. What did they expect??
MMs exchanging “shares”?
False: insider sells require SEC forms—and compliance is ONE area where they have consistently excelled
+1. Zero accountability and responsiveness to shareholders: ZERO
From page 8 of the filing in late May 2019--perhaps THIS is why they are letting it slide so low (and if so, then they would likely let it languish here until most of the notes are satisfied): "The effects of the dilutive securities were anti-dilutive due to net loss during the three-month period ended March 31, 2019 and 2018."
I would imagine that listing invalid contact information on SEC forms would prompt a fine, no?
+1
I called for the ouster of the non-scientists over a year ago. “Dereliction of duty” doesn’t even BEGIN to capture the essence, in my view.
Can you believe what we are witnessing, doc? Under what conceivable scenario does this recover? Have we been had?
Some of us have been “patient” for going on 2 years—during which time we commercialized, read of a contract with Dr. Pushkar in Russia (the details of which STILL TO THIS DAY have not even been SUMMARIZED by the company), and Gershman et.al. have been talking about 90ish% CaverStem efficacy on social media. But in the almost complete absence of follow-up by the company, a vacuum was created: and the market, like Nature, abhors a vacuum...
My assessment is crazy—or this situation?
How in the HELL does a stock almost on the verge of POSITIVE EPS but trading at roughly 1/20 of ONE CENT have a chance?? Call me crazy...
Yeah—happened 3 weeks ago...
Not quite sure how this is possible, but price is dancing around in the last 30 minutes or so up and down 1-2 ticks around .0007, but the VOLUME hasn’t moved from 102,853,551???
Remember when you used to say you have to have ice water in your veins down here? That’s when we were still in pennies. Do you hold out any serious hope for this ticker, SFL?
If they stand by idly and allow this to flop and fold (rather than ACTIVELY AND AGGRESSIVELY promote their business and raise this back to a respectable valuation), I can PROMISE you that they will never be able to advertise their names as anything other than incompetent, disingenuous, and malfeasant in any professional circle again.
Who’s our shorter?
Who said anything about 100%? “Highly effective” within a statistical context means something north of 60%—and I believe it’s likely that CaverStem will be safely in the 80% range
Can someone enlighten me about any meaningful differences—functionally, legally, financially, etc—between “R” and “TM”? I note that three in this list have the one designation, while the fourth has the other.
Like the last one: first 100% day ever, followed by an even faster erosive collapse than we saw falling from .07 over several months? No thanks—tired of games
Down 98% since 2018, even as revs have INCREASED—precisely the OPPOSITE of the direction PPS should be going in. This week will mark one YEAR since trial concluded—and still no publication.
Training of docs on CaverStem/FemCelz continues at a GLACIAL pace: according to my best reckoning of the revs vs. COGS, under 50 procedures were performed during the entire QUARTER that ended on 6/30/2019. What a farce. Where’s the beef?
Meantime, as of the most recent filing, EPS continues to improved—UP from -.01 to essentially 0. With positive EPS seemingly on the horizon (based on the trend), how CRAZY is it for the current PPS to be mired at 1/10 of one penny? What am I missing in this equation (the financials are what they are)?
Again, I MUST ask this question until it gets answered: whose interest is advanced by having the PPS THIS DAMN LOW? What is the logic here?
Not sure what you’re referring to, but I’m talking about the clinical trial that concluded on 8/28/18–I recall it vividly because that’s my birthday (but instead of a gift on that day or 8/28 of this year, all they’ve been serving me is a sick series of gag gifts).
More to the point (and this came into my head again as I was reading the last 10-Q and 8-K): it is only because we have NO shareholder call that ANY confusion can not only exist but PERSIST. WE NEED A QUARTERLY CALL (totally agreed, Corruption Fighter)!!!
Just emailed Dickerson—we shall see....
I agree with almost everything you wrote here, monte. However, they are making it VERY difficult for thinking people to believe that they have ANY ability to “know what we own” (the theoretically sound advice given by the “damn the torpedoes” crowd for some while now. In the absence of clear guidance, we are left guessing and hoping—and that’s FAR from an easy and acceptable place to be.
So maybe then we can get back to, say, .02? As for “soon,” we’ve been crying “wolf” for damn long now that I forget what we were even sounding off about...
Buffet’s never even heard of CELZ
Someone replied on there, called the poster out (with expletives), and declared it to be fake news. Whom to believe...
GLACIAL PROGRESS. Almost 2 years after liftoff. 90+% worse off now than then. There IS no defense.
They have given us NOTHING to hang out hats on, nothing to legitimize belief. These statements are incontrovertible. “Hope and change”: how did that work out. SHOW US THE GOODS?
That’s 300M in a month and a half—a 25% increase from the prior level on 8/1. They’d better get their f’ing act together and BRING THE GOODS (and the news thereof), or they are TOAST. Dickerson’s reputation (MBA from USC) and Ichim’s will be SHOT if they f*** this up. Sorry—but RESULTS MATTER.
They would need to determine a valuation for only that portion of CELZ’ overall portfolio
I disagree: at what point, after 2 years of hints about CaverStem’s efficacy (and even explicit statements) by involved parties does this gain ANY sustained traction. On the very reasonable supposition that there was fire where we sense smoke, this shot from .01-.07 in a matter of a few months. Now, with the earnings per share on the verge of turning POSITIVE, we have tanked to 1/10 of ONE PENNY? Worse still, anyone who may happen to stumble across CELZ on their own (because the company’s reticent and glacial advance is doing NOTHING to promote itself far and wide within the public consciousness) will see this price action (read “CRASH”) and naturally wonder what in the absolute hell is going on here...
What are the note conversion price points in relation to where we are/have been? Let’s say the average of last week was .0018–how do the note conversions compare? I think this may hold at least PART of the answer to our riddle...
When shorts cover, there is huge BUYING...